FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 336:41-48 January 2, 1997 Number 1 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

The indications for providing nutrients by the enteral or intravenous route (nutritional support) are not well defined, and the efficacy of nutritional support in many circumstances is unproved. Nonetheless, nutritional support is widely used for several reasons: malnutrition is common in hospitalized patients,^1,2 there is an association between malnutrition and increased morbidity^3,4 and mortality,⁵ it seems intuitively likely that well-nourished patients will respond most favorably to treatment, nutritional support can be administered safely to most patients, and clinical trials indicate that it is beneficial in selected patients.^6,7,8,9,10

Virtually all patients can be fed intravenously or enterally, because of the development . . . [Full Text of this Article]

Identification of Malnourished Patients

Indications for Nutritional Support

Major Elective Surgery

Major Trauma

Bone Marrow Transplantation

Unproved Benefits of Nutritional Support

Chemotherapy and Radiation Therapy for Cancer

Acquired Immunodeficiency Syndrome

Gastrointestinal Tract Dysfunction

Liver Failure

Renal Failure

Optimal Route of Delivery and Composition of Nutritional Formulas

Benefits and Costs of Nutritional Support

Future Directions and Conclusions

Source Information

From the Division of Surgical Oncology and the Nutrition Support Service, Massachusetts General Hospital and Harvard Medical School, Boston.

Address reprint requests to Dr. Souba at Massachusetts General Hospital, Cox Bldg., Rm. 626, 100 Blossom St., Boston, MA 02114.

References

This article has been cited by other articles:

• Bechard, L. J., Guinan, E. C., Feldman, H. A., Tang, V., Duggan, C. (2007). Prognostic Factors in the Resumption of Oral Dietary Intake After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Children. JPEN J Parenter Enteral Nutr 31: 295-301 [Abstract] [Full Text]  
• Todd, S. R., Kozar, R. A., Moore, F. A. (2006). Nutrition Support in Adult Trauma Patients. Nutr Clin Pract 21: 421-429 [Abstract] [Full Text]  
• Hubert-Buron, A., Leblond, J., Jacquot, A., Ducrotte, P., Dechelotte, P., Coeffier, M. (2006). Glutamine Pretreatment Reduces IL-8 Production in Human Intestinal Epithelial Cells by Limiting I{kappa}B{alpha} Ubiquitination. J. Nutr. 136: 1461-1465 [Abstract] [Full Text]  
• Mok, E., Violante, C. E.-D., Daubrosse, C., Gottrand, F., Rigal, O., Fontan, J.-E., Cuisset, J.-M., Guilhot, J., Hankard, R. (2006). Oral glutamine and amino acid supplementation inhibit whole-body protein degradation in children with Duchenne muscular dystrophy.. Am. J. Clin. Nutr. 83: 823-828 [Abstract] [Full Text]  
• Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., Bouillon, R. (2006). Intensive Insulin Therapy in the Medical ICU. NEJM 354: 449-461 [Abstract] [Full Text]  
• Thomas, D. R. (2006). Guidelines for the Use of Orexigenic Drugs in Long-Term Care. Nutr Clin Pract 21: 82-87 [Abstract] [Full Text]  
• Seres, D. S. (2005). Surrogate Nutrition Markers, Malnutrition, and Adequacy of Nutrition Support. Nutr Clin Pract 20: 308-313 [Abstract] [Full Text]  
• Coeffier, M., Hecketsweiler, B., Hecketsweiler, P., Dechelotte, P. (2005). Effect of glutamine on water and sodium absorption in human jejunum at baseline and during PGE1-induced secretion. J. Appl. Physiol. 98: 2163-2168 [Abstract] [Full Text]  
• Carroll, P. V., Jackson, N. C., Russell-Jones, D. L., Treacher, D. F., Sonksen, P. H., Umpleby, A. M. (2004). Combined growth hormone/insulin-like growth factor I in addition to glutamine-supplemented TPN results in net protein anabolism in critical illness. Am. J. Physiol. Endocrinol. Metab. 286: E151-E157 [Abstract] [Full Text]  
• Coeffier, M., Claeyssens, S., Hecketsweiler, B., Lavoinne, A., Ducrotte, P., Dechelotte, P. (2003). Enteral glutamine stimulates protein synthesis and decreases ubiquitin mRNA level in human gut mucosa. Am. J. Physiol. Gastrointest. Liver Physiol. 285: G266-G273 [Abstract] [Full Text]  
• Duggan, C., Bechard, L., Donovan, K., Vangel, M., O'Leary, A., Holmes, C., Lehmann, L., Guinan, E. (2003). Changes in resting energy expenditure among children undergoing allogeneic stem cell transplantation. Am. J. Clin. Nutr. 78: 104-109 [Abstract] [Full Text]  
• Krishnan, J. A., Parce, P. B., Martinez, A., Diette, G. B., Brower, R. G. (2003). Caloric Intake in Medical ICU Patients: Consistency of Care With Guidelines and Relationship to Clinical Outcomes. Chest 124: 297-305 [Abstract] [Full Text]  
• Coeffier, M., Le Pessot, F., Leplingard, A., Marion, R., Lerebours, E., Ducrotte, P., Dechelotte, P. (2002). Acute Enteral Glutamine Infusion Enhances Heme Oxygenase-1 Expression in Human Duodenal Mucosa. J. Nutr. 132: 2570-2573 [Abstract] [Full Text]  
• van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., Bouillon, R. (2001). Intensive Insulin Therapy in Critically Ill Patients. NEJM 345: 1359-1367 [Abstract] [Full Text]  
• Zauner, C., Schuster, B. I, Schneeweiss, B. (2001). Similar metabolic responses to standardized total parenteral nutrition of septic and nonseptic critically ill patients. Am. J. Clin. Nutr. 74: 265-270 [Abstract] [Full Text]  
• Van den Berghe, G., Weekers, F., Baxter, R. C., Wouters, P., Iranmanesh, A., Bouillon, R., Veldhuis, J. D. (2001). Five-Day Pulsatile Gonadotropin-Releasing Hormone Administration Unveils Combined Hypothalamic-Pituitary-Gonadal Defects Underlying Profound Hypoandrogenism in Men with Prolonged Critical Illness. J. Clin. Endocrinol. Metab. 86: 3217-3226 [Abstract] [Full Text]  
• Billings, J A. (2000). Recent advances: Palliative care. BMJ 321: 555-558 [Full Text]  
• Young, V. R., Ajami, A. M. (2000). Glutamate: An Amino Acid of Particular Distinction. J. Nutr. 130: 892-892 [Abstract] [Full Text]  
• Schwenk, A., Beisenherz, A., Kremer, G., Diehl, V., Salzberger, B., Fatkenheuer, G. (1999). Bioelectrical impedance analysis in HIV-infected patients treated with triple antiretroviral treatment. Am. J. Clin. Nutr. 70: 867-873 [Abstract] [Full Text]  
• Van den Berghe, G., Wouters, P., Weekers, F., Mohan, S., Baxter, R. C., Veldhuis, J. D., Bowers, C. Y., Bouillon, R. (1999). Reactivation of Pituitary Hormone Release and Metabolic Improvement by Infusion of Growth Hormone-Releasing Peptide and Thyrotropin-Releasing Hormone in Patients with Protracted Critical Illness. J. Clin. Endocrinol. Metab. 84: 1311-1323 [Abstract] [Full Text]  
• FIACCADORI, E., LOMBARDI, M., LEONARDI, S., ROTELLI, C. F., TORTORELLA, G., BORGHETTI, A. (1999). Prevalence and Clinical Outcome Associated with Preexisting Malnutrition in Acute Renal Failure: A Prospective Cohort Study. J. Am. Soc. Nephrol. 10: 581-593 [Abstract] [Full Text]  
• Van den Berghe, G., Wouters, P., Carlsson, L., Baxter, R. C., Bouillon, R., Bowers, C. Y. (1998). Leptin Levels in Protracted Critical Illness: Effects of Growth Hormone-Secretagogues and Thyrotropin-Releasing Hormone. J. Clin. Endocrinol. Metab. 83: 3062-3070 [Abstract] [Full Text]  
• Bonten, M. J. M., Slaughter, S., Ambergen, A. W., Hayden, M. K., van Voorhis, J., Nathan, C., Weinstein, R. A. (1998). The Role of "Colonization Pressure" in the Spread of Vancomycin-Resistant Enterococci: An Important Infection Control Variable. Arch Intern Med 158: 1127-1132 [Abstract] [Full Text]  
• Van den Berghe, G., de Zegher, F., Baxter, R. C., Veldhuis, J. D., Wouters, P., Schetz, M., Verwaest, C., Van der Vorst, E., Lauwers, P., Bouillon, R., Bowers, C. Y. (1998). Neuroendocrinology of Prolonged Critical Illness: Effects of Exogenous Thyrotropin-Releasing Hormone and Its Combination with Growth Hormone Secretagogues. J. Clin. Endocrinol. Metab. 83: 309-319 [Abstract] [Full Text]